Showing 121-130 of 333 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Comprehensive Landscape Study on Biomaterials in T1D | Quaestio Global Partners, LLC | Magdy Abdel-Malik | Cures | 14-March-2025 to 30-June-2025 | $55,000.00 |
| Clinical Validation of a Smart Bolus Calculator Informed by Insulin Sensitivity in Adults and Adolescents with Type 1 Diabetes | Rector & Visitors of the University of Virginia | Chiara Fabris | Improving Lives | 01-June-2020 to 31-December-2025 | $604,390.26 |
| Pancreatic Islet Transplantation for the Treatment of Type 1 Diabetes: In-Silico Developments to Support Clinical Advancements | Rector & Visitors of the University of Virginia | Chiara Fabris | Cures | 01-January-2025 to 31-December-2025 | $299,916.19 |
| Leveraging Real-Time Insulin Sensitivity Estimation for the Adaptation of a Fully-Closed Loop Automated Insulin Delivery System to Improve Glycemic Control in Adolescents with Type 1 Diabetes | Rector & Visitors of the University of Virginia | H. Marcela Moscoso Vasquez | Improving Lives | 01-April-2024 to 31-March-2026 | $189,709.00 |
| Development of simulation tools to support adaptation of automated insulin delivery algorithms across pregnancies complicated by type 1 diabetes | Rector & Visitors of the University of Virginia | Jacopo Pavan | Improving Lives | 01-March-2025 to 28-February-2027 | $189,316.00 |
| Anti-CD71 immunotherapy to restore T cell homeostasis in autoimmunity | Rector & Visitors of the University of Virginia | Kelsey Voss | Cures | 01-September-2025 to 31-August-2026 | $150,000.00 |
| The role of iron metabolism in T cell subsets in type 1 diabetes | Rector & Visitors of the University of Virginia | Kelsey Voss | Cures | 01-March-2025 to 28-February-2026 | $110,000.00 |
| Preclinical Optimization of Polyclonal IgM for Type 1 Diabetes Prevention and Reversal | Rector & Visitors of the University of Virginia | Kenneth Brayman | Cures | 01-July-2024 to 30-June-2025 | $249,500.00 |
| S1P transport inhibitors for prevention of T1D | Rector & Visitors of the University of Virginia | Kevin Lynch | Cures | 01-October-2024 to 30-September-2026 | $520,627.00 |
| Improving prediction of T1D risk by establishing a self-administered CGM-based technology and whole genome-based polygenic risk scores in diverse populations | Rector & Visitors of the University of Virginia | Leon Farhy | Cures | 01-August-2022 to 31-July-2025 | $599,999.66 |